The Challenge of Change - Managing Excipients Control
Colorcon
| « Previous month | Next month » |
Sanofi-Aventis will build a new manufacturing plant in King Abdullah Economic City (KAEC) in Saudi Arabia through an agreement with the Emaar development company (ECC).
in-PharmaTechnologist presents its latest round up of movements in the pharma space, including appointments at DSM, Codexis, USP and MonoSol Rx.
Colorcon has added processing and formulation development capacity at its technical service laboratory in Cotia near Sao Paulo, Brazil.
Suzhou Erye, a subsidiary of NeoStem Pharmaceutical, has passed inspection by the Chinese Food and Drug Administration (SFDA) meaning the company's new manufacturing facility will go ahead with the manufacture of penicillin and cephalosporin powder for injection.
India’s oldest pharmaceutical company Alembic went one step closer to the biggest restructuring in its history as its board approved the demerging of its main pharmaceutical business into a separate subsidiary company, Alembic Pharma.
West Pharmaceutical Services and Japan’s Daikyo Seiko team on container technology they claim will help drugmakers ensure consistency during scale-up operations
Results from PAT humidity monitoring research will improve API granulation process, product yields and reduce variability during drug manufacture, says NextPharma.
Norwegian bio-chemicals producer Borregaard is closing down its production facility in Italy due to “challenging market conditions.”
Sosei has revealed its intention to acquire Activus Pharma in a deal which allows the Japan-based firm to get their hands on Activus' nanoparticle drug formulation tools, a technology that’s in its infancy but holds great potential.
Piramal Healthcare has signalled its intent to enter the biotechnology sector with its acquisition of BioSyntech in a deal worth $3.8m and includes full access to BioSyntech’s proprietary biotherapeutic thermogel technology.
A deal to broaden Gilead’s research expertise into protein kinase biology has been finalised with the $120m acquisition of CGI Pharmaceuticals, in a deal that compliments its comprehensive selection of anti-HIV treatments.
Tanabe Research Labs (TRL) has revealed details of its new San Diego facility in which the revised layout of the site allows a fresh focus on antibody and biological approaches to autoimmune diseases such as diabetes and rheumatoid arthritis.
New Gerresheimer CEO Uwe Roehrhoff wants the German firm to become the pharmaceutical and biopharmaceutical industry “first choice” partner for high-tech packaging.
Regulus Therapeutics’ microRNA satellite technology has won the firm its biggest deal to date with French drugmaker Sanofi-Aventis agreeing a development accord worth up to $750m (€606m).
Baxter Healthcare is expanding its European R&D presence with a new facility designed to take new pharmaceuticals from “conception to registration.”
Pfizer will use “virtual” patients to test the efficacy of candidate drugs though a new deal with Entelos.
Aphios has been awarded a patent that details an improved process to formulate a polymer-based drug delivery nanotechnology platform. The method offers a more sustainable, consistent administration of therapeutics with less dosage-dependent side effects.
A new technique developed by researchers has yielded results, which suggests that drug production and manufacturing can essentially be achieved without toxic by-products.
ViroPharma is seeking permission from the Food and Drug Administration (FDA) to increase production of Cinryze to an industrial scale as part of its ongoing expansion activities.
US drugmaker Merck & Co’s new deal with Adcock Ingram proves the FIFA football World Cup isn’t the only thing attracting people to South Africa this summer.
Schott Pharmaceutical Packaging has revealed details of its US-based ready-to-fill syringe production line capabilities in a manufacturing sector that has traditionally been the strong hold of countries like Germany and France.
US supplier SAFC recently expanded its liquid cell culture reagents in response to growing biomanufacturing industry demand.
French drug maker Sanofi-Aventis continues to spearhead the fight for a more secure pharmaceutical supply chain by launching an anti-counterfeit medication initiative in Egypt.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including changes at Relypsa, Genzyme, Benitec, Genmab, Celsion, Alligator Bioscience.
Canada’s Biovail plans to buy Valeant Pharmaceuticals to strengthen US position in specialty CNS, dermatology and generics markets.
Pharmaceutical and healthcare carton specialists, Chesapeake has formed an alliance with carton supplier Cartonajes Leca in a move that aims to extend its production network to southern Europe.
Pharmaceutical manufacturers should consider solvent recovery as the US government looks to establish mandates for greenhouse gas emissions, according to Rockwell Automation.
Researchers believe they have found a way of transforming a key element of liquid crystal display (LCD) televisions into a substance that can be used in pills and dressings designed to deliver drugs to certain parts of the body.
SPX Corporation has announced its Flow Technology division is to acquire Anhydro A/S as it highlighted processing expansion in the food and pharmaceutical sectors as a key part of its growth strategy.
Ricerca Biosciences has been licensed by the DEA to handle multiple kilos of controlled Schedule II-V substances at its site in Concord, Ohio, US.
Vetter Pharma have begun construction of its latest storage facility in a move that forms part of Vetter’s recent efforts to expand its pharmaceutical logistical resources. Vetter's newest facility, located in Germany, adds to another new U.S facility as it seeks to meet differing but strict product storage and integrity standards worldwide.
Pfizer continues its foray into rare diseases as it creates a new R&D unit to investigate novel therapeutics for conditions such as Haemophilia. The pharma giant joins GlaxoSmithKline and Novartis as companies looking into producing specialised drugs as a way to offset slowing sales growth and loss of blockbuster patent protection.
Egypt-based Minapharm has acquired 95 per cent of CMO ProBioGen for a possible total of €30.4m ($37.6m).
CSL Behring is to supply clinical and commercial quantities of plasma-based fibrinogen and thrombin to ProFibrix.
Malaysia is “an ideal location to manufacture generics”, according to F&S, and this could drive growth and investment in the country.
Nilfisk CFM has introduced the next generation of its single-phase industrial vacuum cleaners, S2 and S3.
Amcor said its takeover of Ball Plastics Packaging Americas for US$280m is an important strategic move that will allow it to diversify packaging formats, as well as expand its manufacturing capabilities and market share.
ATMI and Sartorius Stedim Biotech (SSB) have extended their global supply and marketing agreement to include the Magnetic Mixer technology.
The role of the pharma industry in supporting the COE anti-counterfeiting treaty, which aims to criminalise activities, “cannot be underestimated”, according to a directorate member.
Nearly half of healthcare supply chain executives are planning to expand into emerging markets in the next 18 months, according to a UPS survey, but are concerned about the process.
AMRI has acquired Hyaluron for $27m (€22m) to enter the prefilled syringe market and expand the customer base for its existing operations.
Pall and New Brunswick have teamed up to develop and supply new disposable bioreactor technologies, targeting growing demand for products that improve quality and reduce cost of biomanufacturing.
The DCGI has banned import of raw materials from 10 Chinese companies which lacked mandatory manufacturing standards, according to The Economic Times of India .
BioScale has secured $25m (€21m) to fund commercialisation of its ViBE protein analytics systems.
Evonik has strengthened its precious metal powder catalysts business, opening a production site in Shanghai, China and buying an Indian company.
Parabolic Drugs will enter India’s CRAMS sector with new dedicated manufacturing facilities designed to attract “global innovator companies” enabling its business to grow in regulated markets.
OptiNose is to take its nasal drug delivery device into Phase III using $48.5m (€40m) a private equity firm has agreed to invest in the business.
Cadila Pharmaceuticals and Novavax have completed construction of their joint venture vaccine manufacturing plant in Dholka, India.
in-PharmaTechnologist presents its latest round up of movements in the sector, including appointments at Pfizer, Biocodex, Unigene, Pieris and Progenics.
Know your Lilly from your Lonza? Then test your industry knowledge against colleagues, peers and our community of readers by participating in our exclusive map-based quiz.
Water used by pharmaceutical manufacturing facilities is being released into the environment with drug concentrations that are up to 1000 times higher than normal according to a study conducted by the US Geological Survey (USGS).
Xcellerex is building a second cGMP FlexFactory biomanufacturing facility to support clients transitioning to their own plants and provide contract manufacturing services.
MonoSol Rx and Applied Pharma Research have agreed to expand their working partnership to produce and market current prescription drug products in film form. This method of drug delivery has gained much momentum recently as an innovative and novel form of administering medication.
Counterfeit and unlicensed treatments for depression and erectile dysfunction have been seized in London and Yorkshire, UK during raids by the MHRA.
GlaxoSmithKline (GSK) has described media reports of an overall review of operations in Ireland as “completely inaccurate”, telling in-PharmaTechnologist that the exercise only covers the plant in Cork.
Becton Dickinson (BD) is launching what could be the world’s smallest pen needle designed for insulin delivery. Patients in the United States will be the first recipients as BD aim to head up a market worth roughly $174bn (€145bn).
Lonza is to collaborate with France’s Cellectis SA for the development and commercialisation of a bioengineered cell line.
DSM is providing process development and current good manufacturing practice (cGMP) production of a Clostridium difficile molecule for Novacta Biosystems.
The Consortium for the Advancement of Patient Safety (CAPS) says research shows that USP plans to restrict printing on pharmaceutical vial ferrules and caps are “ambiguous and vague.”
Increasing customer demand for integrated and flexible systems were the drivers behind developing new vertical flat pouch equipment for packing a range of free-flowing goods including granulates and powders, said Bosch Packaging Technology.
LGR Emballages, has announced a substantial investment in three Speedmaster XL 105 presses that the French packaging group hope will improve its current short-run productivity for pharmaceutical packaging.
KV Pharmaceuticals has decided to cut its losses and sell its subsidiary Particle Dynamics in a deal worth $24.6m (€20.6m). The deal adds some much needed stability as the business attempts to shore up its finances during a difficult period.
Ceco Environmental has launched a product capable of destroying volatile organic compounds (VOC) and removing nitrous oxides (NOx) from airstreams.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Genzyme adding more manufacturing experience and resignations at Uluru and Par.
Nampak Europe is to invest €4.5m ($5.4m) in a new purpose-built factory to replace its Wolfen facility in a move to reduce product costs in the northern European arm of the business.
Caraco’s work plan setting out remedial actions needed to restart production at its Detroit-based plant has been approved by the FDA.
Philips and RXi Pharmaceuticals have formed a research agreement to investigate combining their technologies for delivery of RNA interference (RNAi).
Spain-based Grifols has agreed to acquire Talecris for $3.4bn (€2.8bn) in cash and stock to increase its presence in North America.
An anti-counterfeiting pilot project in Nigeria, which uses a mobile authentication service (MAS) to validate genuine medication, has completed a 100-day pilot phase. Preliminary results suggest the scheme is well on the way to becoming an effective defence against counterfeit drugs and other products.
American chemicals maker Cambrex has announced its active pharmaceutical ingredient (API) manufacturing facility has completed a successful FDA inspection.
X-ray transparency and added durability are benefits of a new conveyor belt that helps improve performance for contaminant detection in glass containers on food and pharmaceutical lines, said Mettler Toledo Safeline.
Malaysia is keen to attract Indian biopharm companies and is offering incentives and infrastructure to encourage firms to establish manufacturing operations, according to local media reports.
The USP is strengthening links with Eastern Europe and Russia by agreeing to share quality standards with Ukraine and offering training courses in Moscow.
ISP Pharmaceuticals has expanded its extrusion spheronisation offering with the installation of new dedicated technology at its laboratory in Sao Paulo, Brazil.
Indian API manufacturer Shasun Chemicals and Drugs turned a previous loss into profit for Q4 of this year as it seeks to make a dent in the biosimilar manufacturing sector.
India-based Surya Pharmaceuticals is planning to raise Rs 500 crore ($100m) to fund construction of an active pharmaceutical ingredient (API) production plant, according to local media reports.
China-based Sinovac Biotech has been selected to supply a hepatitis A vaccine, Healive, to the Beijing Expanded Program of Immunization.
Indian-based drug makers continue to come under intense scrutiny by the US Food and Drug Administration (FDA) as the regulatory body issues warnings to healthcare professionals not to use certain brands of antibiotics due to potential contamination.
Irish pharmaceutical company Elan says most potential investors are positive about proposal to spin-off drug delivery unit.
New research could make it possible for scientists to use silicon particles as an effective drug delivery system that enables fragile small interfering RNA (siRNA) based drugs to be directly transported to the disease’s location.
Ampac Flexibles continues to utilise its High-Speed (HS) Laminate technology by launching its laminate films – a product, which the makers claim will heat seal at temperatures 40 degrees lower than standard laminate materials.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Pfizer and AstraZeneca naming R&D leaders and appointments at APV and Lonza.
Claris has initiated a recall of three antibiotics it manufactures, which are also sold by Sagent, Pfizer and West-Ward, after the FDA warned of contamination.
| « Previous month | Next month » |